These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31570430)

  • 1. Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma.
    Woo HY; DO SI; Kim SH; Song SY; Kim HS
    Anticancer Res; 2019 Oct; 39(10):5361-5367. PubMed ID: 31570430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
    Jung YY; Sung JY; Kim JY; Kim HS
    Anticancer Res; 2018 Feb; 38(2):691-697. PubMed ID: 29374692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
    Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
    BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma.
    Kim JY; Kim SH; Kim HS
    Anticancer Res; 2019 May; 39(5):2361-2367. PubMed ID: 31092428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell translocation gene 1 is downregulated by promoter methylation in ovarian carcinoma.
    Kim JY; Do SI; Bae GE; Kim HS
    J Cancer; 2017; 8(14):2669-2675. PubMed ID: 28928854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
    Kanda M; Sugimoto H; Nomoto S; Oya H; Hibino S; Shimizu D; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Feb; 46(2):641-8. PubMed ID: 25405901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells.
    Zhang M; Wang Q; Yuan W; Yang S; Wang X; Yan JD; Du J; Yin J; Gao SY; Sun BC; Zhu TH
    J Steroid Biochem Mol Biol; 2007; 105(1-5):91-7. PubMed ID: 17574840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].
    Wang R; Li LW; Wang RL; Fan QX; Zhao PR; Wang LX; Lu SH
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):894-7. PubMed ID: 17533738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3.
    Li X; Wu Y; Liu A; Tang X
    Biochem Biophys Res Commun; 2016 Sep; 477(4):768-773. PubMed ID: 27363334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells.
    Aumsuwan P; Khan SI; Khan IA; Avula B; Walker LA; Helferich WG; Katzenellenbogen BS; Dasmahapatra AK
    In Vitro Cell Dev Biol Anim; 2015 Jan; 51(1):59-71. PubMed ID: 25148825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.
    Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V
    Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 18. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
    Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
    OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
    Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
    Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.
    Liu J; Zhang X; Liu A; Zhang D; Su Y; Liu Y; You D; Yuan L; Kong X; Wang X; Sun P
    Oncotarget; 2016 Jun; 7(24):36755-36766. PubMed ID: 27191984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.